[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-295976-105":59,"doc-detail-295976-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","implementing-the-national-optimal-lung-cancer-pathway-november-2018-membership-and-acknowledgements","IMPLEMENTING THE NATIONAL OPTIMAL LUNG CANCER PATHWAY - NOVEMBER 2018 - MEMBERSHIP AND ACKNOWLEDGEMENTS","","Implements the National Optimal Lung Cancer Pathway (NOLCP) and documents the coalition framework around the UK Lung Cancer Coalition (UKLCC). Describes the Clinical Advisory Group (CAG) composition, including senior clinicians across palliative medicine, medical oncology, respiratory medicine, pathology, nursing, and thoracic surgery, plus supporting patient and clinical groups. Sets out the UKLCC’s campaigning aims, meeting sponsorship, and financial support, then introduces the foreword, strategy context, and the rationale for adopting NOLCP to improve lung cancer outcomes in England and across devolved services.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/implementing-the-national-optimal-lung-cancer-pathway-november-2018-membership-and-acknowledgements/295976/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/implementing-the-national-optimal-lung-cancer-pathway-november-2018-membership-and-acknowledgements/295976.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-22","2026-09-18",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the National Optimal Lung Cancer Pathway (NOLCP) and why is it being implemented?","Question",{"text":112,"@type":113},"NOLCP is described as a practical road map and tool to improve lung cancer care. It is being prioritised so cancer alliances and services can organise facilities and people to drive measurable improvements in outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Who is included in the UKLCC Clinical Advisory Group (CAG)?",{"text":117,"@type":113},"The CAG is made up of senior clinicians representing specialties involved in lung cancer care, spanning suspicion and diagnosis through palliative care. The document lists doctors, professors, nurses, and clinical leaders across multiple NHS and academic organisations.",{"name":119,"@type":110,"acceptedAnswer":120},"What support, sponsorship, and financial backing are mentioned?",{"text":121,"@type":113},"The document lists leading patient and clinical groups supporting the CAG. It also notes sponsorship for the meeting on improving outcomes in England and identifies organisations that financially support the work of UKLCC.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},295976,1789726542,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":129,"read_time":143},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","IMPLEMENTING THE NATIONAL OPTIMAL LUNG CANCER PATHWAY  \nNOVEMBER 2018  \nMEMBERSHIP AND ACKNOWLEDGEMENTS  \nThe UKLCC’s Clinical Advisory Group (CAG) is a panel of senior clinicians, each representing particular specialities involved in the care of lung cancer patients, from the time of first suspicion of the diagnosis through to palliative care.  \nThe members of the group are:  \nDr Andrew Wilcock  \nClinical Reader in Palliative Medicine and Medical Oncology, Nottingham University Hospitals NHS Trust  \nMs Carol Stonham MBE Nurse Practitioner, NHS Gloucestershire CCG  \nDr Ian Williamson  \nConsultant Respiratory Physician, Assistant Medical Director for Cancer Services, Aneurin Bevan University Health Board  \nDr Jason Lester  \nConsultant Clinical Oncologist, Velindre Cancer Centre  \nProfessor Keith Kerr  \nConsultant Pathologist, Aberdeen Royal Infirmary  \nMs Lavinia Magee  \nNurse Consultant, Thoracic Oncology, Papworth Hospital NHS Foundation Trust  \nProfessor Michael Lind Professor of Medical Oncology, University of Hull  \nDr Michael Snee  \nConsultant Clinical Oncologist, Leeds Teaching Hospitals NHS Trust Professor Mick Peake (Chair)  \nClinical Director, Centre for Cancer Outcomes, Cancer Collaborative, UCLH; Emeritus Consultant and Honorary Professor of Respiratory Medicine, University of Leicester; Honorary Clinical Lead, National Cancer Registration and Analysis Service (NCRAS), Public Health England  \nMr Naidu Babu  \nConsultant Thoracic Surgeon, Birmingham Heartlands Hospital  \nMr Richard Steyn  \nConsultant Thoracic Surgeon; Deputy Medical Director, University Hospitals Birmingham NHS Foundation Trust; Honorary Associate Professor, University of Warwick and Chair of the UKLCC  \nDr Robert Rintoul  \nConsultant Chest Physician, Department of Thoracic Oncology, Papworth Hospital NHS Foundation Trust  \nDr Steve Holmes  \nGeneral Practitioner, The Park Medical Practice, Shepton Mallet, Somerset  \nDr Wendy Anderson  \nConsultant Respiratory Physician, Antrim; Northern Ireland Lung Cancer Co-Lead  \nMiss Juliet King  \nConsultant Thoracic Surgeon and Clinical Lead, Thoracic Surgery, Guysand St Thomas’ NHS Foundation Trust  \nMr Doug West  \nConsultant Thoracic Surgeon, University Hospitals Bristol NHS Foundation Trust  \nProfessor Denis Talbot  \nProfessor of Cancer Medicine & Consultant in Medical Oncology, Oxford University  \nDr Ian Woolhouse  \nConsultant Respiratory Physician, University Hospitals of Birmingham NHS Foundation Trust  \nMr Martin Grange  \nPatient representative, and member of the Lung Cancer Screening Advisory Group  \nThe CAG is also supported by leading patient and clinical group members, including:  \n— British Lung Foundation  \n— British Thoracic Oncology Group  \n— British Thoracic Society  \n— Cancer Black Care  \n— Cancer Research UK  \n— Macmillan Cancer Support  \n— National Lung Cancer Forum for Nurses  \n— Primary Care Respiratory Society  \n— Roy Castle Lung Cancer Foundation  \n—Tenovus Cancer Care  \nThe meeting ‘Making the very best use of NHS resources and opportunities to improve outcomes for lung cancer patients in England’ was sponsored by the following:  \n— MSD  \n— East of England NHS Trust  \n— UCLH NHS Foundation Trust  \n— University Hospitals of South Manchester NHS Trust  \nThe work of the UKLCC is financially supported by the following:  \n— Bristol-Myers Squibb  \n— Roche Products Ltd  \n— MSD  \nABOUT THE UKLCC  \nThe United Kingdom Lung Cancer Coalition (UKLCC)–the country’s largest multi-interest group in lung cancer – is a coalition of the UK’s leading lung cancer experts, senior NHS professionals, charities and healthcare companies.  \nThrough our campaigning activity we aim to:  \n— Raise political awareness of lung cancer  \n— Raise the general public’s awareness of lung cancer – and especially encourage earlier presentation and symptom recognition  \n— Empower patients to take an active part in their care  \n— Improve lung cancer services  \nCONTACT DETAILS  \nThe UKLCC is keen to work with all interested organisat","cbCaigRj0gvnIfsq","https://ap.wps.com/l/cbCaigRj0gvnIfsq","pdf",1932878,"English","# Membership and Acknowledgements\n## About the UKLCC\n## Contact Details\n# Contents\n## Foreword\n## Introduction\n## The imperative for implementing the National Optimal Lung Cancer Pathway\n## Initiatives to support the implementation of NOLCP\n## Practical considerations when implementing the NOLCP\n## Conclusion\n## Case studies\n## Spotlight on optimising the Lung Cancer Pathway\n## Agenda and presentations\n## References","[{\"question\":\"What is the National Optimal Lung Cancer Pathway (NOLCP) and why is it being implemented?\",\"answer\":\"NOLCP is described as a practical road map and tool to improve lung cancer care. It is being prioritised so cancer alliances and services can organise facilities and people to drive measurable improvements in outcomes.\"},{\"question\":\"Who is included in the UKLCC Clinical Advisory Group (CAG)?\",\"answer\":\"The CAG is made up of senior clinicians representing specialties involved in lung cancer care, spanning suspicion and diagnosis through palliative care. The document lists doctors, professors, nurses, and clinical leaders across multiple NHS and academic organisations.\"},{\"question\":\"What support, sponsorship, and financial backing are mentioned?\",\"answer\":\"The document lists leading patient and clinical groups supporting the CAG. It also notes sponsorship for the meeting on improving outcomes in England and identifies organisations that financially support the work of UKLCC.\"}]","IMPLEMENTING THE NATIONAL OPTIMAL LUNG CANCER PATHWAY - NOVEMBER 2018 - MEMBERSHIP AND ACKNOWLEDGEMENTS | PDF",48]